← Evidence map

ArticlemedRxiv : the preprint server for health sciences2025

Plasma vs. serum: which is better for proteomic blood biomarker analysis? Evaluation of the novel NULISA platform.

Marissa F Farinas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41282836